1WE
(2S)-1-phenylpropan-2-amine
| Created: | 2013-07-05 |
| Last modified: | 2020-05-26 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 23 |
| Chiral Atom Count | 1 |
| Bond Count | 23 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | (2S)-1-phenylpropan-2-amine |
| Synonyms | Dextroamphetamine; D-amphetamine; Dexamphetamine; Dexedrine; Dextrostat |
| Systematic Name (OpenEye OEToolkits) | (2S)-1-phenylpropan-2-amine |
| Formula | C9 H13 N |
| Molecular Weight | 135.206 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | NC(Cc1ccccc1)C |
| SMILES | CACTVS | 3.385 | C[CH](N)Cc1ccccc1 |
| SMILES | OpenEye OEToolkits | 1.7.6 | CC(Cc1ccccc1)N |
| Canonical SMILES | CACTVS | 3.385 | C[C@H](N)Cc1ccccc1 |
| Canonical SMILES | OpenEye OEToolkits | 1.7.6 | C[C@@H](Cc1ccccc1)N |
| InChI | InChI | 1.03 | InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1 |
| InChIKey | InChI | 1.03 | KWTSXDURSIMDCE-QMMMGPOBSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB01576 |
|---|---|
| Name | Dextroamphetamine |
| Description | Dextroamphetamine is the dextrorotary enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label]. |
| Synonyms |
|
| Indication | Dextroamphetamine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).[Label] |
| Categories |
|
| ATC-Code | N06BA02 |
| CAS number | 51-64-9 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Synaptic vesicular amine transporter | MALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYS... | unknown | inducer |
| Sodium-dependent noradrenaline transporter | MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD... | unknown | negative modulator |
| Sodium-dependent dopamine transporter | MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP... | unknown | negative modulator |
| Trace amine-associated receptor 1 | MMPFCHNIINISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISH... | unknown | agonist |
| Alpha-1B adrenergic receptor | MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGL... | unknown | antagonist |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL612 |
| PubChem | 5826 |
| ChEMBL | CHEMBL612 |
| ChEBI | CHEBI:4469 |
| CCDC/CSD | FANJAG, AMPETS |














